A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to determine the maximum tolerated dose (MTD) of BEZ235 and
BKM120 in combination with weekly paclitaxel and weekly paclitaxel/trastuzumab.